The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms
Biofilm formation is often associated with increased Candida resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of biofilm formation among Candida isolates and to investigate the effect of high doses of fluconazole {FLC}, voriconazole {VOC} and amphoteric...
Saved in:
Published in | Saudi pharmaceutical journal Vol. 23; no. 1; pp. 55 - 66 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Saudi Arabia
Elsevier B.V
01.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Biofilm formation is often associated with increased Candida resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of biofilm formation among Candida isolates and to investigate the effect of high doses of fluconazole {FLC}, voriconazole {VOC} and amphotericin B {AMB}, singly and in combination on mature biofilms. Moreover, it aimed to assess the expression of selected genes (CDR1, KRE1 and SKN1) responsible for Candida biofilm resistance. The study included 49 patients; samples were collected from the King Khalid Hospital, Riyadh, Saudi Arabia. Isolates were prepared for biofilm formation and quantification using 0.4% (w/v) crystal violet. Minimum Inhibitory concentration (MIC) and fractional inhibitory concentration (FIC) were conducted by the broth microdilution method. Biofilm eradication was evaluated using counting, XTT stain intensity and observed under the inverted microscope. Selected genes were evaluated in Candida biofilms under the effect of antifungal exposure using QPCR. The major isolates were Candida albicans (65.3%) followed by Candida tropicalis and Candida glabrata. 77.6% of the strains were biofilm formers. AMB showed susceptibility in 87.8% of isolates, followed by VOC (77.6%) and FLC (67.3%). MIC50 and MIC90 were (0.03, 0.125), (0.5, 8), (2, >128) μg/ml for AMB, VOC and FLC, respectively. 34.7% and 18.4% of the isolates were antagonistic to AMB/FLC and AMB/VOC, respectively. Mature biofilms of ten selected isolates were found resistant to FLC (1000μg/ml). VOR and AMB concentration required to inhibit biofilm formation was 16–250 fold higher than the MIC for planktonic cells. Isolates showed significant reduction with antifungal combination when compared with the untreated controls (p value⩽0.01), or using fluconazole alone (p value⩽0.05). High doses of the antifungals were employed to assess the effect on the persisters’ selected gene expression. Marked over expression of SKN1 and to a lesser extent KRE1 was noticed among the mature biofilms treated with AMB alone or in combination after 1h of exposure, and SKN1 expression was even more sharply induced after 24h. No statistically significant over expression of CDR1 was observed in biofilms after exposure to high doses of FLC, VOC or any of the combinations used. |
---|---|
AbstractList | Biofilm formation is often associated with increased
Candida
resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of biofilm formation among
Candida
isolates and to investigate the effect of high doses of fluconazole {FLC}, voriconazole {VOC} and amphotericin B {AMB}, singly and in combination on mature biofilms. Moreover, it aimed to assess the expression of selected genes (CDR1, KRE1 and SKN1) responsible for
Candida
biofilm resistance. The study included 49 patients; samples were collected from the King Khalid Hospital, Riyadh, Saudi Arabia. Isolates were prepared for biofilm formation and quantification using 0.4% (w/v) crystal violet. Minimum Inhibitory concentration (MIC) and fractional inhibitory concentration (FIC) were conducted by the broth microdilution method. Biofilm eradication was evaluated using counting, XTT stain intensity and observed under the inverted microscope. Selected genes were evaluated in
Candida
biofilms under the effect of antifungal exposure using QPCR. The major isolates were
Candida albicans
(65.3%) followed by
Candida tropicalis
and
Candida glabrata
. 77.6% of the strains were biofilm formers. AMB showed susceptibility in 87.8% of isolates, followed by VOC (77.6%) and FLC (67.3%). MIC50 and MIC90 were (0.03, 0.125), (0.5, 8), (2, >128) μg/ml for AMB, VOC and FLC, respectively. 34.7% and 18.4% of the isolates were antagonistic to AMB/FLC and AMB/VOC, respectively. Mature biofilms of ten selected isolates were found resistant to FLC (1000 μg/ml). VOR and AMB concentration required to inhibit biofilm formation was 16–250 fold higher than the MIC for planktonic cells. Isolates showed significant reduction with antifungal combination when compared with the untreated controls (
p
value ⩽ 0.01), or using fluconazole alone (
p
value ⩽ 0.05). High doses of the antifungals were employed to assess the effect on the persisters’ selected gene expression. Marked over expression of SKN1 and to a lesser extent KRE1 was noticed among the mature biofilms treated with AMB alone or in combination after 1 h of exposure, and SKN1 expression was even more sharply induced after 24 h. No statistically significant over expression of CDR1 was observed in biofilms after exposure to high doses of FLC, VOC or any of the combinations used. Biofilm formation is often associated with increased Candida resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of biofilm formation among Candida isolates and to investigate the effect of high doses of fluconazole {FLC}, voriconazole {VOC} and amphotericin B {AMB}, singly and in combination on mature biofilms. Moreover, it aimed to assess the expression of selected genes (CDR1, KRE1 and SKN1) responsible for Candida biofilm resistance. The study included 49 patients; samples were collected from the King Khalid Hospital, Riyadh, Saudi Arabia. Isolates were prepared for biofilm formation and quantification using 0.4% (w/v) crystal violet. Minimum Inhibitory concentration (MIC) and fractional inhibitory concentration (FIC) were conducted by the broth microdilution method. Biofilm eradication was evaluated using counting, XTT stain intensity and observed under the inverted microscope. Selected genes were evaluated in Candida biofilms under the effect of antifungal exposure using QPCR. The major isolates were Candida albicans (65.3%) followed by Candida tropicalis and Candida glabrata. 77.6% of the strains were biofilm formers. AMB showed susceptibility in 87.8% of isolates, followed by VOC (77.6%) and FLC (67.3%). MIC50 and MIC90 were (0.03, 0.125), (0.5, 8), (2, >128) μg/ml for AMB, VOC and FLC, respectively. 34.7% and 18.4% of the isolates were antagonistic to AMB/FLC and AMB/VOC, respectively. Mature biofilms of ten selected isolates were found resistant to FLC (1000 μg/ml). VOR and AMB concentration required to inhibit biofilm formation was 16-250 fold higher than the MIC for planktonic cells. Isolates showed significant reduction with antifungal combination when compared with the untreated controls (p value ⩽ 0.01), or using fluconazole alone (p value ⩽ 0.05). High doses of the antifungals were employed to assess the effect on the persisters' selected gene expression. Marked over expression of SKN1 and to a lesser extent KRE1 was noticed among the mature biofilms treated with AMB alone or in combination after 1 h of exposure, and SKN1 expression was even more sharply induced after 24 h. No statistically significant over expression of CDR1 was observed in biofilms after exposure to high doses of FLC, VOC or any of the combinations used. Biofilm formation is often associated with increased Candida resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of biofilm formation among Candida isolates and to investigate the effect of high doses of fluconazole {FLC}, voriconazole {VOC} and amphotericin B {AMB}, singly and in combination on mature biofilms. Moreover, it aimed to assess the expression of selected genes (CDR1, KRE1 and SKN1) responsible for Candida biofilm resistance. The study included 49 patients; samples were collected from the King Khalid Hospital, Riyadh, Saudi Arabia. Isolates were prepared for biofilm formation and quantification using 0.4% (w/v) crystal violet. Minimum Inhibitory concentration (MIC) and fractional inhibitory concentration (FIC) were conducted by the broth microdilution method. Biofilm eradication was evaluated using counting, XTT stain intensity and observed under the inverted microscope. Selected genes were evaluated in Candida biofilms under the effect of antifungal exposure using QPCR. The major isolates were Candida albicans (65.3%) followed by Candida tropicalis and Candida glabrata. 77.6% of the strains were biofilm formers. AMB showed susceptibility in 87.8% of isolates, followed by VOC (77.6%) and FLC (67.3%). MIC50 and MIC90 were (0.03, 0.125), (0.5, 8), (2, >128) μg/ml for AMB, VOC and FLC, respectively. 34.7% and 18.4% of the isolates were antagonistic to AMB/FLC and AMB/VOC, respectively. Mature biofilms of ten selected isolates were found resistant to FLC (1000μg/ml). VOR and AMB concentration required to inhibit biofilm formation was 16–250 fold higher than the MIC for planktonic cells. Isolates showed significant reduction with antifungal combination when compared with the untreated controls (p value⩽0.01), or using fluconazole alone (p value⩽0.05). High doses of the antifungals were employed to assess the effect on the persisters’ selected gene expression. Marked over expression of SKN1 and to a lesser extent KRE1 was noticed among the mature biofilms treated with AMB alone or in combination after 1h of exposure, and SKN1 expression was even more sharply induced after 24h. No statistically significant over expression of CDR1 was observed in biofilms after exposure to high doses of FLC, VOC or any of the combinations used. |
Author | Somily, Ali M. Melake, Nahla A. Zakaria, Azza S. Mahmoud, Amany Z. Ibrahim, Nermin H. Baddour, Manal M. |
AuthorAffiliation | c Medical Microbiology and Immunology Department, Faculty of Medicine, Menoufia University, Egypt a Medical Microbiology and Immunology Department, Faculty of Medicine, Beni Suef University, Egypt d Microbiology Department, Faculty of Medicine, King Saud University, Saudi Arabia f Medical Microbiology and Immunology Department, Faculty of Medicine, Alexandria University, Egypt e Microbiology Department, Faculty of Pharmacy, Alexandria University, Egypt g Pharmaceutical Medicinal Chemistry Department, College of Pharmacy, Assiut University, Egypt b Pharmaceutics Department, College of Pharmacy, King Saud University, Saudi Arabia |
AuthorAffiliation_xml | – name: d Microbiology Department, Faculty of Medicine, King Saud University, Saudi Arabia – name: f Medical Microbiology and Immunology Department, Faculty of Medicine, Alexandria University, Egypt – name: e Microbiology Department, Faculty of Pharmacy, Alexandria University, Egypt – name: a Medical Microbiology and Immunology Department, Faculty of Medicine, Beni Suef University, Egypt – name: c Medical Microbiology and Immunology Department, Faculty of Medicine, Menoufia University, Egypt – name: g Pharmaceutical Medicinal Chemistry Department, College of Pharmacy, Assiut University, Egypt – name: b Pharmaceutics Department, College of Pharmacy, King Saud University, Saudi Arabia |
Author_xml | – sequence: 1 givenname: Nermin H. surname: Ibrahim fullname: Ibrahim, Nermin H. email: nerhassan@gmail.com organization: Medical Microbiology and Immunology Department, Faculty of Medicine, Beni Suef University, Egypt – sequence: 2 givenname: Nahla A. surname: Melake fullname: Melake, Nahla A. organization: Medical Microbiology and Immunology Department, Faculty of Medicine, Menoufia University, Egypt – sequence: 3 givenname: Ali M. surname: Somily fullname: Somily, Ali M. organization: Microbiology Department, Faculty of Medicine, King Saud University, Saudi Arabia – sequence: 4 givenname: Azza S. surname: Zakaria fullname: Zakaria, Azza S. organization: Pharmaceutics Department, College of Pharmacy, King Saud University, Saudi Arabia – sequence: 5 givenname: Manal M. surname: Baddour fullname: Baddour, Manal M. organization: Medical Microbiology and Immunology Department, Faculty of Medicine, Alexandria University, Egypt – sequence: 6 givenname: Amany Z. surname: Mahmoud fullname: Mahmoud, Amany Z. organization: Pharmaceutics Department, College of Pharmacy, King Saud University, Saudi Arabia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25685044$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU-L3CAYh6Vs6c5u-wV6KDn2ktTXaBKhFMrQf7DQy_YsRl9nHRKdarKwH6PfuM7MdmkvBcGDz--nvs8VuQgxICGvgTZAoXu3b_b5kBtGoW2ANZT2z8iGMWjrnvfigmygBVkXkl-Sq5z3lDIhZPuCXDLRDYJyviG_bu-wQufQLFV0lQ6Ld2vY6akycR590IuPoSprSTpkk_xhySewyuuY8RSyad3VCbPPiw4Gqx0GzJUPlZl88KZ0-RwnveApudXBelvyBzT-xNnVoK1GH52f5vySPHd6yvjqcb8mPz5_ut1-rW--f_m2_XhTG8HEUjvOxCAtMs4daoPGyVF2AzPGjHYEwbqWD5Qb4KIFbq2UHEYLdGRgJfRDe00-nHsP6zijNRjKFyd1SH7W6UFF7dW_J8HfqV28V7wFKjteCt4-FqT4c8W8qNlng9OkA8Y1K-iE6BnvJRSUnVGTYs4J3dM1QNXRpdqro0t1dKmAqeKyhN78_cCnyB95BXh_BrCM6d5jUrlMtBiwPhWfykb_v_7fen-2RQ |
CitedBy_id | crossref_primary_10_1007_s11274_023_03609_0 crossref_primary_10_2174_1874285801610010012 crossref_primary_10_1097_MD_0000000000004474 crossref_primary_10_1111_myc_12436 crossref_primary_10_1007_s12094_021_02738_y crossref_primary_10_1016_j_bjm_2016_12_008 crossref_primary_10_15171_PS_2018_41 crossref_primary_10_4155_fmc_2022_0062 crossref_primary_10_3390_jof7050351 |
Cites_doi | 10.1128/AAC.00463-08 10.1016/j.resmic.2010.02.004 10.1093/jac/dkp429 10.1128/JCM.42.5.2275-2278.2004 10.1086/323759 10.1128/IAI.70.2.878-888.2002 10.1128/AAC.45.6.1660-1670.2001 10.1128/AAC.00684-06 10.1093/jac/28.suppl_B.27 10.1128/IAI.71.8.4333-4340.2003 10.1086/380796 10.3810/pgm.2013.05.2650 10.1086/421946 10.1093/infdis/168.2.400 10.1128/AAC.34.2.183 10.1155/2012/528521 10.1128/AAC.42.12.3065 10.1007/s12281-010-0035-5 10.1093/jac/27.4.491 10.1128/AAC.39.11.2378 10.1080/1120009X.1990.11738981 10.1128/AAC.45.10.2676-2684.2001 10.1128/AAC.47.11.3657-3659.2003 10.1128/AAC.45.9.2475-2479.2001 10.1128/AAC.00997-06 10.1023/A:1007283211220 10.1093/jac/dks242 10.1099/jmm.0.46817-0 10.1002/(SICI)1097-0061(19980430)14:6<517::AID-YEA250>3.0.CO;2-D 10.1128/AAC.41.7.1482 10.1111/j.1439-0507.2009.01690.x 10.1128/AAC.46.6.1773-1780.2002 10.1128/IAI.62.3.915-921.1994 10.1093/infdis/167.5.1247 10.1111/j.1567-1364.2006.00117.x 10.1128/AAC.00791-10 10.1128/AAC.38.6.1331 10.1111/j.1601-0825.2007.01424.x 10.1128/AAC.00280-11 10.1042/bst0211034 10.1128/AAC.49.6.2226-2236.2005 10.1128/AAC.42.11.2932 10.9734/BMRJ/2013/5028 10.1016/j.archoralbio.2011.03.007 10.1128/AAC.39.9.2128 10.1016/S0065-2911(08)60307-0 10.1128/JB.183.18.5385-5394.2001 10.1128/AAC.00856-07 10.1146/annurev.micro.112408.134306 10.1186/gb-2002-3-7-research0034 10.1128/AAC.42.8.1900 10.1046/j.1439-0507.1999.00498.x 10.1128/jb.179.7.2363-2372.1997 10.1128/AAC.01397-07 10.1093/jac/dkf049 10.1590/S1517-83822010000400029 10.1016/S0076-6879(99)10044-2 10.1016/S0076-6879(99)10050-8 10.1016/j.ijid.2006.03.003 |
ContentType | Journal Article |
Copyright | 2013 Saudi Pharmaceutical Journal 2015 King Saud University. Production and hosting by Elsevier B.V. All rights reserved. 2013 Saudi Pharmaceutical Journal |
Copyright_xml | – notice: 2013 Saudi Pharmaceutical Journal – notice: 2015 King Saud University. Production and hosting by Elsevier B.V. All rights reserved. 2013 Saudi Pharmaceutical Journal |
DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.jsps.2013.12.007 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2213-7475 |
EndPage | 66 |
ExternalDocumentID | 10_1016_j_jsps_2013_12_007 25685044 S1319016413001187 |
Genre | Journal Article |
GroupedDBID | --- --K 0R~ 0SF 123 1B1 4.4 457 53G 5VS 6I. 71M AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAQFI AAXUO ABMAC ACGFO ACGFS ADBBV ADEZE ADMUD AENEX AEXQZ AFTJW AGHFR AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BCNDV DIK DU5 E3Z EBS EJD EP3 FDB FEDTE FNPLU GROUPED_DOAJ GX1 HH5 HVGLF HYE HZ~ IPNFZ IXB KQ8 NCXOZ O-L O9- OK1 OZT P2P RIG ROL RPM SES SSZ TR2 XH2 ~S- ADVLN AFJKZ AKRWK NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c525t-f42589de244feacecf9b9682cccbdb152634804c145314dd9941bd10b21d91783 |
IEDL.DBID | RPM |
ISSN | 1319-0164 |
IngestDate | Tue Sep 17 21:00:48 EDT 2024 Fri Oct 25 08:36:18 EDT 2024 Thu Sep 26 16:12:12 EDT 2024 Sat Sep 28 08:03:56 EDT 2024 Fri Feb 23 02:34:40 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Candida spp KRE1 Biofilm Antifungal SKN1 CDR1 |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c525t-f42589de244feacecf9b9682cccbdb152634804c145314dd9941bd10b21d91783 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1319016413001187 |
PMID | 25685044 |
PQID | 1655724791 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4310964 proquest_miscellaneous_1655724791 crossref_primary_10_1016_j_jsps_2013_12_007 pubmed_primary_25685044 elsevier_sciencedirect_doi_10_1016_j_jsps_2013_12_007 |
PublicationCentury | 2000 |
PublicationDate | 2015-01-01 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Saudi Arabia |
PublicationPlace_xml | – name: Saudi Arabia |
PublicationTitle | Saudi pharmaceutical journal |
PublicationTitleAlternate | Saudi Pharm J |
PublicationYear | 2015 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | LaFleur, Kumamoto, Lewis (b0140) 2006; 50 Petrou, Rogers (b0240) 1991; 27 Pappas, Rex, Sobel, Filler, Dismukes, Walsh, Edwards (b0230) 2004; 38 National Committee for Clinical Laboratory Standards, 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Second Edition: Approved Standard M27–A2. NCCLS, Wayne, PA, USA. Sanglard, Kuchler, Ischer, Pagani, Monod, Bille (b0280) 1995; 39 Tunney, Patrick, Curran, Ramage, Anderson, Davis, Gorman, Nixon (b0305) 1999; 310 Lewis (b0145) 2010; 64 Bachmann, Ramage, VandeWalle, Patterson, Wickes, Lo’pez-Ribot (b0015) 2003; 47 Richardson (b0270) 1990; 2 Tobudic, Lassnigg, Kratzer, Graninger, Presterl (b0300) 2010; 53 Ng, Saw, Na, Soo-Hoo (b0215) 2000; 149 Ramage, Bachmann, Patterson, Wickes, López-Ribot (b0250) 2002; 49 Hawser, Douglas (b0095) 1995; 39 Seneviratne, Jin, Samaranayake (b0290) 2008; 14 Vandesompele, De Preter, Pattyn, Poppe, Van Roy, De Paepe, Speleman (b0320) 2002; 3 Beggs, Holmes, Cannon, Rich (b0035) 2004; 42 Beck-Sagué, Jarvis (b0030) 1993; 167 Khot, Suci, Miller, Nelson, Tyler (b0125) 2006; 50 Perea, López-Ribot, Kirkpatrick, McAtee, Santillán, Martínez, Calabrese, Sanglard, Patterson (b0235) 2001; 45 Al-Tawfiq (b0005) 2007; 11 Sardi, Almeida, Mendes Giannini (b0285) 2011; 56 Uppuluri, Nett, Heitman, Andes (b0310) 2008; 52 Lopez-Ribot, McAtee, Lee, Kirkpatrick, White, Sanglard, Patterson (b0160) 1998; 42 Mokaddas, Al-Sweih, Khan (b0185) 2007; 56 Liu, Lee, Barker, Lee, Wei, Homayouni, Rogers (b0155) 2005; 49 Nucci, Anaissie (b0220) 2001; 33 White (b0330) 1997; 41 Brajtburg, Powderly, Kobayashi, Medoff (b0045) 1990; 34 Martinez, Fries (b0170) 2010; 4 Rodrigues, Santos, Tagliari, Rizzo, Trenhago, Oliveira, Goetz, Nascimento (b0275) 2010; 41 Ramage, VandeWalle, Wickes, Lopez-Ribot (b0265) 2001; 45 Valentin, Canton, Peman, Martinez (b0315) 2012; 67 Emam, Abo Elazm, Morad (b0070) 2012; 8 Martin, Maier, Bhakdi (b0165) 1994; 38 Mukherjee, Chandra, Kuhn, Ghannoum (b0195) 2003; 71 Ece, Samlioglu, Akkoclu, Atalay, Kose (b0065) 2012; 2012 Mohamed, Al-Ahmadey (b0180) 2013; 3 Baillie, Douglas (b0020) 1998; 42 Franz, Ruhnke, Morschhäuser (b0080) 1999; 42 Nyirjesy, Sobel (b0225) 2013; 125 Wisplinghoff, Bischoff, Tallent, Seifert, Wenzel, Edmond (b0335) 2004; 39 Chandra, Kuhn, Mukherjee, Hoyer, McCormick, Ghannoum (b0050) 2001; 183 Franz, Kelly, Lamb, Kelly, Ruhnke, Morschhäuser (b0075) 1998; 42 Moody (b0190) 1991; vol. 1 Warnock (b0325) 1991; 28 Nailis, Vandenbosch, Deforce, Nelis, Coenye (b0205) 2010; 161 De Backer, Ilyina, Ma, Vandonink, Luyten, Vanden Bossche (b0055) 2001; 45 Katragkou, Chatzimoschou, Simitsopoulou, Dalakiouridou, Diza-Mataftsi, Tsantali, Roilides (b0115) 2008; 52 Kuhn, George, Chandra, Mukherjee, Ghannoum (b0135) 2002; 46 Hawser, Douglas (b0090) 1994; 62 Lignell, Lowdin, Cars, Sanglard, Sjolin (b0150) 2011; 55 Helmi (b0100) 2009; 18 Kuhn, Chandra, Ghannou (b0130) 2002; 70 Hernáez, Gil, Pla, Nombelas (b0105) 1998; 14 Raad, Costerton, Sabharwal, Sacilowski, Anaissie, Bodey (b0245) 1993; 168 Mio, Yamada-Okabe, Yabe, Nakajima, Arisawa, Yamada-Okabe (b0175) 1997; 179 Muller, Janovjak, Miserez, Dobbie (b0200) 2002; 32 Holmes, Lin, Niimi, Lamping, Keniya, Niimi, Tanabe, Monk, Cannon (b0110) 2008; 52 Al-Jasser, Elkhizzi (b0010) 2004; 25 Baillie, Douglas (b0025) 1999; 310 Douglas, Cobbs (b0060) 1992 Tobudic, Kratzer, Lassnigg, Graninger, Presterl (b0295) 2010; 65 Gale (b0085) 1986; 27 Kelly, Arnoldi, Kelly (b0120) 1993; 21 Bink, Vandenbosch, Coenye, Nelis, Cammue, Thevissen (b0040) 2011; 55 Ramage, Rajendran, Sherry, Williams (b0260) 2012; 2012 Ramage, Martínez, López-Ribot (b0255) 2006; 6 8335977 - J Infect Dis. 1993 Aug;168(2):400-7 11796623 - Infect Immun. 2002 Feb;70(2):878-88 12184808 - Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 12074169 - Biotechniques. 2002 Jun;32(6):1372-4, 1376, 1378-9 8486965 - J Infect Dis. 1993 May;167(5):1247-51 19076549 - Oral Dis. 2008 Oct;14(7):582-90 9835492 - Antimicrob Agents Chemother. 1998 Dec;42(12):3065-72 21676377 - Arch Oral Biol. 2011 Oct;56(10):951-9 8112864 - Infect Immun. 1994 Mar;62(3):915-21 17938192 - Antimicrob Agents Chemother. 2008 Jan;52(1):357-60 8092834 - Antimicrob Agents Chemother. 1994 Jun;38(6):1331-8 14576141 - Antimicrob Agents Chemother. 2003 Nov;47(11):3657-9 2183713 - Antimicrob Agents Chemother. 1990 Feb;34(2):183-8 11307597 - Mycopathologia. 2001;149(3):141-6 12874310 - Infect Immun. 2003 Aug;71(8):4333-40 9797228 - Antimicrob Agents Chemother. 1998 Nov;42(11):2932-7 15131211 - J Clin Microbiol. 2004 May;42(5):2275-8 9687381 - Antimicrob Agents Chemother. 1998 Aug;42(8):1900-5 18710914 - Antimicrob Agents Chemother. 2008 Nov;52(11):3851-62 16966398 - Antimicrob Agents Chemother. 2006 Nov;50(11):3708-16 11502517 - Antimicrob Agents Chemother. 2001 Sep;45(9):2475-9 10547820 - Methods Enzymol. 1999;310:566-76 18180354 - Antimicrob Agents Chemother. 2008 Mar;52(3):1127-32 21660222 - Curr Fungal Infect Rep. 2010 Dec 1;4(4):266-275 19298353 - Mycoses. 2010 May;53(3):208-14 9079924 - J Bacteriol. 1997 Apr;179(7):2363-72 16923951 - Antimicrob Agents Chemother. 2006 Nov;50(11):3839-46 17042747 - FEMS Yeast Res. 2006 Nov;6(7):979-86 3532717 - Adv Microb Physiol. 1986;27:277-320 17244809 - J Med Microbiol. 2007 Feb;56(Pt 2):255-9 20528688 - Annu Rev Microbiol. 2010;64:357-72 23748505 - Postgrad Med. 2013 May;125(3):33-46 19996142 - J Antimicrob Chemother. 2010 Feb;65(2):271-4 8585712 - Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86 24031590 - Braz J Microbiol. 2010 Oct;41(4):1082-5 23028245 - Int J Med Sci. 2012;9(7):617-20 22518145 - Int J Microbiol. 2012;2012:528521 1856128 - J Antimicrob Chemother. 1991 Apr;27(4):491-506 10547826 - Methods Enzymol. 1999;310:644-56 12019089 - Antimicrob Agents Chemother. 2002 Jun;46(6):1773-80 12039889 - J Antimicrob Chemother. 2002 Jun;49(6):973-80 11353609 - Antimicrob Agents Chemother. 2001 Jun;45(6):1660-70 11702290 - Clin Infect Dis. 2001 Dec 15;33(12):1959-67 15306996 - Clin Infect Dis. 2004 Aug 1;39(3):309-17 8131893 - Biochem Soc Trans. 1993 Nov;21(4):1034-8 22733651 - J Antimicrob Chemother. 2012 Oct;67(10):2418-23 10546486 - Mycoses. 1999;42(7-8):453-8 15138521 - Saudi Med J. 2004 May;25(5):566-9 9605502 - Yeast. 1998 Apr 30;14(6):517-26 16859945 - Int J Infect Dis. 2007 May;11(3):239-44 15917516 - Antimicrob Agents Chemother. 2005 Jun;49(6):2226-36 14699449 - Clin Infect Dis. 2004 Jan 15;38(2):161-89 1778890 - J Antimicrob Chemother. 1991 Oct;28 Suppl B:27-38 11557454 - Antimicrob Agents Chemother. 2001 Oct;45(10):2676-84 2332784 - J Chemother. 1990 Feb;2(1):51-4 21282443 - Antimicrob Agents Chemother. 2011 Apr;55(4):1629-37 8540729 - Antimicrob Agents Chemother. 1995 Sep;39(9):2128-31 21746956 - Antimicrob Agents Chemother. 2011 Sep;55(9):4033-7 20170727 - Res Microbiol. 2010 May;161(4):284-92 9210670 - Antimicrob Agents Chemother. 1997 Jul;41(7):1482-7 11514524 - J Bacteriol. 2001 Sep;183(18):5385-94 Helmi (10.1016/j.jsps.2013.12.007_b0100) 2009; 18 Raad (10.1016/j.jsps.2013.12.007_b0245) 1993; 168 Franz (10.1016/j.jsps.2013.12.007_b0075) 1998; 42 Nucci (10.1016/j.jsps.2013.12.007_b0220) 2001; 33 Khot (10.1016/j.jsps.2013.12.007_b0125) 2006; 50 Nyirjesy (10.1016/j.jsps.2013.12.007_b0225) 2013; 125 Ramage (10.1016/j.jsps.2013.12.007_b0265) 2001; 45 Hawser (10.1016/j.jsps.2013.12.007_b0095) 1995; 39 Katragkou (10.1016/j.jsps.2013.12.007_b0115) 2008; 52 Muller (10.1016/j.jsps.2013.12.007_b0200) 2002; 32 Mukherjee (10.1016/j.jsps.2013.12.007_b0195) 2003; 71 Baillie (10.1016/j.jsps.2013.12.007_b0025) 1999; 310 Brajtburg (10.1016/j.jsps.2013.12.007_b0045) 1990; 34 Mokaddas (10.1016/j.jsps.2013.12.007_b0185) 2007; 56 Hawser (10.1016/j.jsps.2013.12.007_b0090) 1994; 62 Lopez-Ribot (10.1016/j.jsps.2013.12.007_b0160) 1998; 42 De Backer (10.1016/j.jsps.2013.12.007_b0055) 2001; 45 Lignell (10.1016/j.jsps.2013.12.007_b0150) 2011; 55 Petrou (10.1016/j.jsps.2013.12.007_b0240) 1991; 27 Seneviratne (10.1016/j.jsps.2013.12.007_b0290) 2008; 14 Mio (10.1016/j.jsps.2013.12.007_b0175) 1997; 179 Richardson (10.1016/j.jsps.2013.12.007_b0270) 1990; 2 Kuhn (10.1016/j.jsps.2013.12.007_b0135) 2002; 46 Baillie (10.1016/j.jsps.2013.12.007_b0020) 1998; 42 Gale (10.1016/j.jsps.2013.12.007_b0085) 1986; 27 Martinez (10.1016/j.jsps.2013.12.007_b0170) 2010; 4 Ramage (10.1016/j.jsps.2013.12.007_b0255) 2006; 6 Emam (10.1016/j.jsps.2013.12.007_b0070) 2012; 8 Al-Jasser (10.1016/j.jsps.2013.12.007_b0010) 2004; 25 Bachmann (10.1016/j.jsps.2013.12.007_b0015) 2003; 47 Ece (10.1016/j.jsps.2013.12.007_b0065) 2012; 2012 Chandra (10.1016/j.jsps.2013.12.007_b0050) 2001; 183 Sanglard (10.1016/j.jsps.2013.12.007_b0280) 1995; 39 Ramage (10.1016/j.jsps.2013.12.007_b0250) 2002; 49 Martin (10.1016/j.jsps.2013.12.007_b0165) 1994; 38 Ramage (10.1016/j.jsps.2013.12.007_b0260) 2012; 2012 Beggs (10.1016/j.jsps.2013.12.007_b0035) 2004; 42 Valentin (10.1016/j.jsps.2013.12.007_b0315) 2012; 67 Al-Tawfiq (10.1016/j.jsps.2013.12.007_b0005) 2007; 11 Tobudic (10.1016/j.jsps.2013.12.007_b0295) 2010; 65 Holmes (10.1016/j.jsps.2013.12.007_b0110) 2008; 52 Perea (10.1016/j.jsps.2013.12.007_b0235) 2001; 45 Bink (10.1016/j.jsps.2013.12.007_b0040) 2011; 55 Pappas (10.1016/j.jsps.2013.12.007_b0230) 2004; 38 Warnock (10.1016/j.jsps.2013.12.007_b0325) 1991; 28 Nailis (10.1016/j.jsps.2013.12.007_b0205) 2010; 161 Douglas (10.1016/j.jsps.2013.12.007_b0060) 1992 Moody (10.1016/j.jsps.2013.12.007_b0190) 1991; vol. 1 Franz (10.1016/j.jsps.2013.12.007_b0080) 1999; 42 Tobudic (10.1016/j.jsps.2013.12.007_b0300) 2010; 53 White (10.1016/j.jsps.2013.12.007_b0330) 1997; 41 Mohamed (10.1016/j.jsps.2013.12.007_b0180) 2013; 3 Sardi (10.1016/j.jsps.2013.12.007_b0285) 2011; 56 Vandesompele (10.1016/j.jsps.2013.12.007_b0320) 2002; 3 LaFleur (10.1016/j.jsps.2013.12.007_b0140) 2006; 50 Beck-Sagué (10.1016/j.jsps.2013.12.007_b0030) 1993; 167 Ng (10.1016/j.jsps.2013.12.007_b0215) 2000; 149 Wisplinghoff (10.1016/j.jsps.2013.12.007_b0335) 2004; 39 10.1016/j.jsps.2013.12.007_b0210 Liu (10.1016/j.jsps.2013.12.007_b0155) 2005; 49 Kuhn (10.1016/j.jsps.2013.12.007_b0130) 2002; 70 Lewis (10.1016/j.jsps.2013.12.007_b0145) 2010; 64 Rodrigues (10.1016/j.jsps.2013.12.007_b0275) 2010; 41 Tunney (10.1016/j.jsps.2013.12.007_b0305) 1999; 310 Uppuluri (10.1016/j.jsps.2013.12.007_b0310) 2008; 52 Kelly (10.1016/j.jsps.2013.12.007_b0120) 1993; 21 Hernáez (10.1016/j.jsps.2013.12.007_b0105) 1998; 14 |
References_xml | – volume: 183 start-page: 5385 year: 2001 end-page: 5394 ident: b0050 article-title: Biofilm formation by the fungal pathogen publication-title: J. Bacteriol. contributor: fullname: Ghannoum – volume: 2012 start-page: 9 year: 2012 ident: b0065 article-title: The evaluation of the distribution of yeast like fungi ‘ publication-title: Int. J. Med. Sci. contributor: fullname: Kose – volume: 38 start-page: 1331 year: 1994 end-page: 1338 ident: b0165 article-title: Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum publication-title: Antimicrob. Agents Chemother. contributor: fullname: Bhakdi – volume: 14 start-page: 517 year: 1998 end-page: 526 ident: b0105 article-title: Induced expression of the publication-title: Yeast contributor: fullname: Nombelas – volume: 41 start-page: 1482 year: 1997 end-page: 1487 ident: b0330 article-title: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in publication-title: Antimicrob. Agents Chemother. contributor: fullname: White – volume: 28 start-page: 27 year: 1991 end-page: 38 ident: b0325 article-title: Amphotericin B: an introduction publication-title: J. Antimicrob. Chemother. contributor: fullname: Warnock – volume: 52 start-page: 1127 year: 2008 end-page: 1132 ident: b0310 article-title: Synergistic effect of calcineurin inhibitors and fluconazole against publication-title: Antimicrob. Agents Chemother. contributor: fullname: Andes – volume: 161 start-page: 284 year: 2010 end-page: 292 ident: b0205 article-title: Transcriptional response to fluconazole and amphotericin B in publication-title: Res. Microbiol. contributor: fullname: Coenye – volume: 2012 start-page: 1 year: 2012 end-page: 14 ident: b0260 article-title: Fungal biofilm resistance publication-title: Int. J. Microbiol. contributor: fullname: Williams – volume: 11 start-page: 239 year: 2007 end-page: 244 ident: b0005 article-title: Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital 1996–2004 publication-title: Int. J. Infect. Dis. contributor: fullname: Al-Tawfiq – volume: 39 start-page: 2378 year: 1995 end-page: 2386 ident: b0280 article-title: Mechanisms of resistance to azole antifungal agents in publication-title: Antimicrob. Agents Chemother. contributor: fullname: Bille – volume: 41 start-page: 1082 year: 2010 end-page: 1085 ident: b0275 article-title: Quantification of biofilm production on polystyrene by Listeria, publication-title: Braz. J. Microbiol. contributor: fullname: Nascimento – volume: 2 start-page: 51 year: 1990 end-page: 54 ident: b0270 article-title: The discovery and profile of fluconazole publication-title: J. Chemother. contributor: fullname: Richardson – volume: 8 start-page: 1392 year: 2012 end-page: 1399 ident: b0070 article-title: Exoenzymes production and antifungal susceptibility of candida species isolated from pregnant women with vulvovaginitis publication-title: J. Am. Sci. contributor: fullname: Morad – volume: 6 start-page: 979 year: 2006 end-page: 986 ident: b0255 article-title: Candida biofilms on implanted biomaterials: a clinically significant problem publication-title: FEMS Yeast Res. contributor: fullname: López-Ribot – volume: 46 start-page: 1773 year: 2002 end-page: 1780 ident: b0135 article-title: Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins publication-title: Antimicrob. Agents Chemother. contributor: fullname: Ghannoum – volume: 32 start-page: 1372 year: 2002 end-page: 1379 ident: b0200 article-title: Processing of gene expression data generated by quantitative real-time RT-PCR publication-title: Biotechniques contributor: fullname: Dobbie – volume: 21 start-page: 1034 year: 1993 end-page: 1038 ident: b0120 article-title: Molecular genetic analysis of azole antifungal mode of action publication-title: Biochem. Soc. Trans. contributor: fullname: Kelly – volume: 65 start-page: 271 year: 2010 end-page: 274 ident: b0295 article-title: In vitro activity of antifungal combinations against publication-title: J. Antimicrob. Chemother. contributor: fullname: Presterl – start-page: 375 year: 1992 end-page: 396 ident: b0060 article-title: Prosthetic valve endocarditis publication-title: Infective Endocarditis contributor: fullname: Cobbs – volume: 53 start-page: 208 year: 2010 end-page: 214 ident: b0300 article-title: Antifungal activity of amphotericin B, caspofungin and posaconazole on publication-title: Mycoses contributor: fullname: Presterl – volume: 27 start-page: 277 year: 1986 end-page: 320 ident: b0085 article-title: Nature and development of phenotypic resistance to amphotericin B in publication-title: Adv. Microb. Physiol. contributor: fullname: Gale – volume: 42 start-page: 2932 year: 1998 end-page: 2937 ident: b0160 article-title: Distinct patterns of gene expression associated with development of fluconazole resistance in serial publication-title: Antimicrob. Agents Chemother. contributor: fullname: Patterson – volume: vol. 1 year: 1991 ident: b0190 article-title: Synergism testing. Broth microdilution checkerboard and Broth microdilution methods publication-title: Clinical Microbiology Procedures Handbook contributor: fullname: Moody – volume: 50 start-page: 3708 year: 2006 end-page: 3716 ident: b0125 article-title: A small subpopulation of blastospores in publication-title: Antimicrob. Agents Chemother. contributor: fullname: Tyler – volume: 52 start-page: 357 year: 2008 end-page: 360 ident: b0115 article-title: Differential activities of newer antifungal agents against publication-title: Antimicrob. Agents Chemother. contributor: fullname: Roilides – volume: 18 start-page: 13 year: 2009 end-page: 22 ident: b0100 article-title: Bloodstream infections due to candida species and antifungal susceptibility profile publication-title: Egypt. J. Med. Microbiol. contributor: fullname: Helmi – volume: 70 start-page: 878 year: 2002 end-page: 888 ident: b0130 article-title: Comparison of biofilms formed by publication-title: Infect Immun. contributor: fullname: Ghannou – volume: 45 start-page: 1660 year: 2001 end-page: 1670 ident: b0055 article-title: Genomic profiling of the response of publication-title: Antimicrob. Agents Chemother. contributor: fullname: Vanden Bossche – volume: 62 start-page: 915 year: 1994 end-page: 921 ident: b0090 article-title: Biofilm formation by Candida species on the surface of catheter materials in vitro publication-title: Infect. Immun. contributor: fullname: Douglas – volume: 52 start-page: 3851 year: 2008 end-page: 3862 ident: b0110 article-title: ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant publication-title: Antimicrob. Agents Chemother. contributor: fullname: Cannon – volume: 50 start-page: 3839 year: 2006 end-page: 3846 ident: b0140 article-title: biofilms produce antifungal-tolerant persister cells publication-title: Antimicrob. Agents Chemother. contributor: fullname: Lewis – volume: 56 start-page: 951 year: 2011 end-page: 959 ident: b0285 article-title: New antimicrobial therapies used against fungi present in subgingival sites: a brief review publication-title: Arch. Oral Biol. contributor: fullname: Mendes Giannini – volume: 38 start-page: 161 year: 2004 end-page: 189 ident: b0230 article-title: Guidelines for treatment of candidiasis publication-title: Clin. Infect. Dis. contributor: fullname: Edwards – volume: 42 start-page: 1900 year: 1998 end-page: 1905 ident: b0020 article-title: Effect of growth rate on resistance of publication-title: Antimicrob. Agents Chemother. contributor: fullname: Douglas – volume: 39 start-page: 2128 year: 1995 end-page: 2131 ident: b0095 article-title: Resistance of publication-title: Antimicrob. Agents Chemother. contributor: fullname: Douglas – volume: 4 start-page: 266 year: 2010 end-page: 275 ident: b0170 article-title: Fungal biofilms: relevance in the setting of human disease publication-title: Curr. Fungal Infect. Rep. contributor: fullname: Fries – volume: 25 start-page: 566 year: 2004 end-page: 569 ident: b0010 article-title: Distribution of Candida species among bloodstream isolates publication-title: Saudi Med. J. contributor: fullname: Elkhizzi – volume: 27 start-page: 491 year: 1991 end-page: 506 ident: b0240 article-title: Interactions in vitro between polyenes and imidazoles against yeast publication-title: J. Antimicrob. Chemother. contributor: fullname: Rogers – volume: 125 start-page: 33 year: 2013 end-page: 46 ident: b0225 article-title: Genital mycotic infections in patients with diabetes publication-title: Postgrad. Med. contributor: fullname: Sobel – volume: 168 start-page: 400 year: 1993 end-page: 407 ident: b0245 article-title: Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement publication-title: J. Infect. Dis. contributor: fullname: Bodey – volume: 67 start-page: 2418 year: 2012 end-page: 2423 ident: b0315 article-title: Voriconazole inhibits biofilm formation in different species of the genus Candida publication-title: J. Antimicrob. Chemother. contributor: fullname: Martinez – volume: 149 start-page: 141 year: 2000 end-page: 146 ident: b0215 article-title: Systemic Candida infection of University Hospital 1997–1999: the distribution of Candida biotypes and antifungal susceptibility patterns publication-title: Mycopathologia contributor: fullname: Soo-Hoo – volume: 167 start-page: 1247 year: 1993 end-page: 1251 ident: b0030 article-title: National nosocomial infections surveillance system secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990 publication-title: J. Infect. Dis. contributor: fullname: Jarvis – volume: 39 start-page: 309 year: 2004 end-page: 317 ident: b0335 article-title: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study publication-title: Clin. Infect. Dis. contributor: fullname: Edmond – volume: 310 start-page: 644 year: 1999 end-page: 656 ident: b0025 article-title: Candida biofilms and their susceptibility to antifungal agents publication-title: Methods Enzymol. contributor: fullname: Douglas – volume: 55 start-page: 1629 year: 2011 end-page: 1637 ident: b0150 article-title: Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone publication-title: Antimicrob. Agents Chemother. contributor: fullname: Sjolin – volume: 179 start-page: 2363 year: 1997 end-page: 2372 ident: b0175 article-title: Isolation of the publication-title: J. Bacteriol. contributor: fullname: Yamada-Okabe – volume: 3 start-page: 590 year: 2013 end-page: 601 ident: b0180 article-title: Biofilm formation and antifungal susceptibility of Candida isolates from various clinical specimens publication-title: Br. Microbiol. Res. J. contributor: fullname: Al-Ahmadey – volume: 42 start-page: 2275 year: 2004 end-page: 2278 ident: b0035 article-title: Detection of publication-title: J. Clin. Microbiol. contributor: fullname: Rich – volume: 14 start-page: 582 year: 2008 end-page: 590 ident: b0290 article-title: Biofilm lifestyle of Candida: a mini review publication-title: Oral Dis. contributor: fullname: Samaranayake – volume: 42 start-page: 3065 year: 1998 end-page: 3072 ident: b0075 article-title: Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical publication-title: Antimicrob. Agents Chemother. contributor: fullname: Morschhäuser – volume: 45 start-page: 2676 year: 2001 end-page: 2684 ident: b0235 article-title: Prevalence of molecular mechanisms of resistance to azole antifungal agents in publication-title: Antimicrob. Agents Chemother. contributor: fullname: Patterson – volume: 34 start-page: 183 year: 1990 end-page: 188 ident: b0045 article-title: Amphotericin B: current understanding of mechanisms of action publication-title: Antimicrob. Agents Chemother. contributor: fullname: Medoff – volume: 64 start-page: 357 year: 2010 end-page: 372 ident: b0145 article-title: Persister cells publication-title: Annu. Rev. Microbiol. contributor: fullname: Lewis – volume: 56 start-page: 255 year: 2007 end-page: 259 ident: b0185 article-title: Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study publication-title: J. Med. Microbiol. contributor: fullname: Khan – volume: 3 year: 2002 ident: b0320 article-title: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes publication-title: Genome Biol. contributor: fullname: Speleman – volume: 47 start-page: 3657 year: 2003 end-page: 3659 ident: b0015 article-title: Antifungal combinations against publication-title: Antimicrob Agents Chemother. contributor: fullname: Lo’pez-Ribot – volume: 49 start-page: 2226 year: 2005 end-page: 2236 ident: b0155 article-title: Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in publication-title: Antimicrob. Agents Chemother. contributor: fullname: Rogers – volume: 55 start-page: 4033 year: 2011 end-page: 4037 ident: b0040 article-title: Superoxide dismutases are involved in publication-title: Antimicrob. Agents Chemother. contributor: fullname: Thevissen – volume: 33 start-page: 1959 year: 2001 end-page: 1967 ident: b0220 article-title: Revisiting the source of candidemia: skin or gut? publication-title: Clin. Infect. Dis. contributor: fullname: Anaissie – volume: 42 start-page: 453 year: 1999 end-page: 458 ident: b0080 article-title: Molecular aspects of fluconazole resistance development in publication-title: Mycoses contributor: fullname: Morschhäuser – volume: 71 start-page: 4333 year: 2003 end-page: 4340 ident: b0195 article-title: Mechanisms of fluconazole resistance in publication-title: Infect. Immun. contributor: fullname: Ghannoum – volume: 310 start-page: 566 year: 1999 end-page: 576 ident: b0305 article-title: Detection of prosthetic joint biofilm infection using immunological and molecular techniques publication-title: Methods Enzymol. contributor: fullname: Nixon – volume: 45 start-page: 2475 year: 2001 end-page: 2479 ident: b0265 article-title: Standardized method for in vitro antifungal susceptibility testing of publication-title: Antimicrob. Agents Chemother. contributor: fullname: Lopez-Ribot – volume: 49 start-page: 973 year: 2002 end-page: 980 ident: b0250 article-title: Investigation of multidrug efflux pumps in relation to fluconazole resistance in publication-title: J. Antimicrob. Chemother. contributor: fullname: López-Ribot – volume: 52 start-page: 3851 issue: 11 year: 2008 ident: 10.1016/j.jsps.2013.12.007_b0110 article-title: ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00463-08 contributor: fullname: Holmes – volume: 161 start-page: 284 issue: 4 year: 2010 ident: 10.1016/j.jsps.2013.12.007_b0205 article-title: Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms publication-title: Res. Microbiol. doi: 10.1016/j.resmic.2010.02.004 contributor: fullname: Nailis – volume: 65 start-page: 271 issue: 2 year: 2010 ident: 10.1016/j.jsps.2013.12.007_b0295 article-title: In vitro activity of antifungal combinations against Candida albicans biofilms publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkp429 contributor: fullname: Tobudic – start-page: 375 year: 1992 ident: 10.1016/j.jsps.2013.12.007_b0060 article-title: Prosthetic valve endocarditis contributor: fullname: Douglas – volume: 42 start-page: 2275 year: 2004 ident: 10.1016/j.jsps.2013.12.007_b0035 article-title: Detection of Candida albicans mRNA in archival histopathology samples by reverse transcription-PCR publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.42.5.2275-2278.2004 contributor: fullname: Beggs – volume: 33 start-page: 1959 issue: 12 year: 2001 ident: 10.1016/j.jsps.2013.12.007_b0220 article-title: Revisiting the source of candidemia: skin or gut? publication-title: Clin. Infect. Dis. doi: 10.1086/323759 contributor: fullname: Nucci – volume: 2012 start-page: 9 year: 2012 ident: 10.1016/j.jsps.2013.12.007_b0065 article-title: The evaluation of the distribution of yeast like fungi ‘Candida Species’ at a tertiary care center in Western Turkey publication-title: Int. J. Med. Sci. contributor: fullname: Ece – volume: 70 start-page: 878 issue: 2 year: 2002 ident: 10.1016/j.jsps.2013.12.007_b0130 article-title: Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces publication-title: Infect Immun. doi: 10.1128/IAI.70.2.878-888.2002 contributor: fullname: Kuhn – volume: 45 start-page: 1660 issue: 6 year: 2001 ident: 10.1016/j.jsps.2013.12.007_b0055 article-title: Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.45.6.1660-1670.2001 contributor: fullname: De Backer – volume: 50 start-page: 3839 issue: 11 year: 2006 ident: 10.1016/j.jsps.2013.12.007_b0140 article-title: Candida albicans biofilms produce antifungal-tolerant persister cells publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00684-06 contributor: fullname: LaFleur – volume: 28 start-page: 27 year: 1991 ident: 10.1016/j.jsps.2013.12.007_b0325 article-title: Amphotericin B: an introduction publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/28.suppl_B.27 contributor: fullname: Warnock – volume: 71 start-page: 4333 issue: 8 year: 2003 ident: 10.1016/j.jsps.2013.12.007_b0195 article-title: Mechanisms of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane esterols publication-title: Infect. Immun. doi: 10.1128/IAI.71.8.4333-4340.2003 contributor: fullname: Mukherjee – volume: 38 start-page: 161 issue: 2 year: 2004 ident: 10.1016/j.jsps.2013.12.007_b0230 article-title: Guidelines for treatment of candidiasis publication-title: Clin. Infect. Dis. doi: 10.1086/380796 contributor: fullname: Pappas – volume: 32 start-page: 1372 year: 2002 ident: 10.1016/j.jsps.2013.12.007_b0200 article-title: Processing of gene expression data generated by quantitative real-time RT-PCR publication-title: Biotechniques contributor: fullname: Muller – volume: 125 start-page: 33 issue: 3 year: 2013 ident: 10.1016/j.jsps.2013.12.007_b0225 article-title: Genital mycotic infections in patients with diabetes publication-title: Postgrad. Med. doi: 10.3810/pgm.2013.05.2650 contributor: fullname: Nyirjesy – volume: 39 start-page: 309 year: 2004 ident: 10.1016/j.jsps.2013.12.007_b0335 article-title: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study publication-title: Clin. Infect. Dis. doi: 10.1086/421946 contributor: fullname: Wisplinghoff – volume: 168 start-page: 400 issue: 2 year: 1993 ident: 10.1016/j.jsps.2013.12.007_b0245 article-title: Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement publication-title: J. Infect. Dis. doi: 10.1093/infdis/168.2.400 contributor: fullname: Raad – volume: 34 start-page: 183 year: 1990 ident: 10.1016/j.jsps.2013.12.007_b0045 article-title: Amphotericin B: current understanding of mechanisms of action publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.34.2.183 contributor: fullname: Brajtburg – volume: 2012 start-page: 1 issue: 528521 year: 2012 ident: 10.1016/j.jsps.2013.12.007_b0260 article-title: Fungal biofilm resistance publication-title: Int. J. Microbiol. doi: 10.1155/2012/528521 contributor: fullname: Ramage – volume: 42 start-page: 3065 issue: 12 year: 1998 ident: 10.1016/j.jsps.2013.12.007_b0075 article-title: Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.42.12.3065 contributor: fullname: Franz – volume: 4 start-page: 266 issue: 4 year: 2010 ident: 10.1016/j.jsps.2013.12.007_b0170 article-title: Fungal biofilms: relevance in the setting of human disease publication-title: Curr. Fungal Infect. Rep. doi: 10.1007/s12281-010-0035-5 contributor: fullname: Martinez – volume: 27 start-page: 491 issue: 4 year: 1991 ident: 10.1016/j.jsps.2013.12.007_b0240 article-title: Interactions in vitro between polyenes and imidazoles against yeast publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/27.4.491 contributor: fullname: Petrou – volume: 39 start-page: 2378 year: 1995 ident: 10.1016/j.jsps.2013.12.007_b0280 article-title: Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.39.11.2378 contributor: fullname: Sanglard – volume: 2 start-page: 51 year: 1990 ident: 10.1016/j.jsps.2013.12.007_b0270 article-title: The discovery and profile of fluconazole publication-title: J. Chemother. doi: 10.1080/1120009X.1990.11738981 contributor: fullname: Richardson – volume: 45 start-page: 2676 issue: 10 year: 2001 ident: 10.1016/j.jsps.2013.12.007_b0235 article-title: Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus infected patients publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.45.10.2676-2684.2001 contributor: fullname: Perea – volume: 47 start-page: 3657 issue: 11 year: 2003 ident: 10.1016/j.jsps.2013.12.007_b0015 article-title: Antifungal combinations against Candida albicans biofilms in vitro publication-title: Antimicrob Agents Chemother. doi: 10.1128/AAC.47.11.3657-3659.2003 contributor: fullname: Bachmann – volume: vol. 1 year: 1991 ident: 10.1016/j.jsps.2013.12.007_b0190 article-title: Synergism testing. Broth microdilution checkerboard and Broth microdilution methods contributor: fullname: Moody – volume: 45 start-page: 2475 year: 2001 ident: 10.1016/j.jsps.2013.12.007_b0265 article-title: Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.45.9.2475-2479.2001 contributor: fullname: Ramage – volume: 50 start-page: 3708 issue: 11 year: 2006 ident: 10.1016/j.jsps.2013.12.007_b0125 article-title: A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and be‘ta-1,6-glucan pathway genes publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00997-06 contributor: fullname: Khot – volume: 149 start-page: 141 issue: 3 year: 2000 ident: 10.1016/j.jsps.2013.12.007_b0215 article-title: Systemic Candida infection of University Hospital 1997–1999: the distribution of Candida biotypes and antifungal susceptibility patterns publication-title: Mycopathologia doi: 10.1023/A:1007283211220 contributor: fullname: Ng – volume: 67 start-page: 2418 issue: 10 year: 2012 ident: 10.1016/j.jsps.2013.12.007_b0315 article-title: Voriconazole inhibits biofilm formation in different species of the genus Candida publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dks242 contributor: fullname: Valentin – volume: 56 start-page: 255 year: 2007 ident: 10.1016/j.jsps.2013.12.007_b0185 article-title: Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study publication-title: J. Med. Microbiol. doi: 10.1099/jmm.0.46817-0 contributor: fullname: Mokaddas – volume: 14 start-page: 517 issue: 6 year: 1998 ident: 10.1016/j.jsps.2013.12.007_b0105 article-title: Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals publication-title: Yeast doi: 10.1002/(SICI)1097-0061(19980430)14:6<517::AID-YEA250>3.0.CO;2-D contributor: fullname: Hernáez – volume: 41 start-page: 1482 year: 1997 ident: 10.1016/j.jsps.2013.12.007_b0330 article-title: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.41.7.1482 contributor: fullname: White – volume: 53 start-page: 208 issue: 3 year: 2010 ident: 10.1016/j.jsps.2013.12.007_b0300 article-title: Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases publication-title: Mycoses doi: 10.1111/j.1439-0507.2009.01690.x contributor: fullname: Tobudic – volume: 46 start-page: 1773 issue: 6 year: 2002 ident: 10.1016/j.jsps.2013.12.007_b0135 article-title: Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.46.6.1773-1780.2002 contributor: fullname: Kuhn – volume: 25 start-page: 566 year: 2004 ident: 10.1016/j.jsps.2013.12.007_b0010 article-title: Distribution of Candida species among bloodstream isolates publication-title: Saudi Med. J. contributor: fullname: Al-Jasser – volume: 62 start-page: 915 issue: 3 year: 1994 ident: 10.1016/j.jsps.2013.12.007_b0090 article-title: Biofilm formation by Candida species on the surface of catheter materials in vitro publication-title: Infect. Immun. doi: 10.1128/IAI.62.3.915-921.1994 contributor: fullname: Hawser – ident: 10.1016/j.jsps.2013.12.007_b0210 – volume: 167 start-page: 1247 year: 1993 ident: 10.1016/j.jsps.2013.12.007_b0030 article-title: National nosocomial infections surveillance system secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990 publication-title: J. Infect. Dis. doi: 10.1093/infdis/167.5.1247 contributor: fullname: Beck-Sagué – volume: 6 start-page: 979 issue: 7 year: 2006 ident: 10.1016/j.jsps.2013.12.007_b0255 article-title: Candida biofilms on implanted biomaterials: a clinically significant problem publication-title: FEMS Yeast Res. doi: 10.1111/j.1567-1364.2006.00117.x contributor: fullname: Ramage – volume: 55 start-page: 1629 issue: 4 year: 2011 ident: 10.1016/j.jsps.2013.12.007_b0150 article-title: Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00791-10 contributor: fullname: Lignell – volume: 38 start-page: 1331 issue: 6 year: 1994 ident: 10.1016/j.jsps.2013.12.007_b0165 article-title: Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.38.6.1331 contributor: fullname: Martin – volume: 14 start-page: 582 issue: 7 year: 2008 ident: 10.1016/j.jsps.2013.12.007_b0290 article-title: Biofilm lifestyle of Candida: a mini review publication-title: Oral Dis. doi: 10.1111/j.1601-0825.2007.01424.x contributor: fullname: Seneviratne – volume: 55 start-page: 4033 issue: 9 year: 2011 ident: 10.1016/j.jsps.2013.12.007_b0040 article-title: Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00280-11 contributor: fullname: Bink – volume: 21 start-page: 1034 issue: 4 year: 1993 ident: 10.1016/j.jsps.2013.12.007_b0120 article-title: Molecular genetic analysis of azole antifungal mode of action publication-title: Biochem. Soc. Trans. doi: 10.1042/bst0211034 contributor: fullname: Kelly – volume: 49 start-page: 2226 issue: 6 year: 2005 ident: 10.1016/j.jsps.2013.12.007_b0155 article-title: Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.49.6.2226-2236.2005 contributor: fullname: Liu – volume: 42 start-page: 2932 issue: 11 year: 1998 ident: 10.1016/j.jsps.2013.12.007_b0160 article-title: Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus infected patients with oropharyngeal candidiasis publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.42.11.2932 contributor: fullname: Lopez-Ribot – volume: 3 start-page: 590 issue: 4 year: 2013 ident: 10.1016/j.jsps.2013.12.007_b0180 article-title: Biofilm formation and antifungal susceptibility of Candida isolates from various clinical specimens publication-title: Br. Microbiol. Res. J. doi: 10.9734/BMRJ/2013/5028 contributor: fullname: Mohamed – volume: 18 start-page: 13 issue: 4 year: 2009 ident: 10.1016/j.jsps.2013.12.007_b0100 article-title: Bloodstream infections due to candida species and antifungal susceptibility profile publication-title: Egypt. J. Med. Microbiol. contributor: fullname: Helmi – volume: 56 start-page: 951 year: 2011 ident: 10.1016/j.jsps.2013.12.007_b0285 article-title: New antimicrobial therapies used against fungi present in subgingival sites: a brief review publication-title: Arch. Oral Biol. doi: 10.1016/j.archoralbio.2011.03.007 contributor: fullname: Sardi – volume: 39 start-page: 2128 issue: 9 year: 1995 ident: 10.1016/j.jsps.2013.12.007_b0095 article-title: Resistance of Candida albicans biofilms to antifungal agents in vitro publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.39.9.2128 contributor: fullname: Hawser – volume: 27 start-page: 277 year: 1986 ident: 10.1016/j.jsps.2013.12.007_b0085 article-title: Nature and development of phenotypic resistance to amphotericin B in Candida albicans publication-title: Adv. Microb. Physiol. doi: 10.1016/S0065-2911(08)60307-0 contributor: fullname: Gale – volume: 183 start-page: 5385 issue: 18 year: 2001 ident: 10.1016/j.jsps.2013.12.007_b0050 article-title: Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance publication-title: J. Bacteriol. doi: 10.1128/JB.183.18.5385-5394.2001 contributor: fullname: Chandra – volume: 52 start-page: 357 issue: 1 year: 2008 ident: 10.1016/j.jsps.2013.12.007_b0115 article-title: Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00856-07 contributor: fullname: Katragkou – volume: 64 start-page: 357 year: 2010 ident: 10.1016/j.jsps.2013.12.007_b0145 article-title: Persister cells publication-title: Annu. Rev. Microbiol. doi: 10.1146/annurev.micro.112408.134306 contributor: fullname: Lewis – volume: 3 issue: 7 year: 2002 ident: 10.1016/j.jsps.2013.12.007_b0320 article-title: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes publication-title: Genome Biol. doi: 10.1186/gb-2002-3-7-research0034 contributor: fullname: Vandesompele – volume: 42 start-page: 1900 year: 1998 ident: 10.1016/j.jsps.2013.12.007_b0020 article-title: Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.42.8.1900 contributor: fullname: Baillie – volume: 42 start-page: 453 issue: 7–8 year: 1999 ident: 10.1016/j.jsps.2013.12.007_b0080 article-title: Molecular aspects of fluconazole resistance development in Candida albicans publication-title: Mycoses doi: 10.1046/j.1439-0507.1999.00498.x contributor: fullname: Franz – volume: 179 start-page: 2363 year: 1997 ident: 10.1016/j.jsps.2013.12.007_b0175 article-title: Isolation of the Candida albicans homologs of Saccharomyces cerevisiae KRE6 and SKN1: expression and physiological function publication-title: J. Bacteriol. doi: 10.1128/jb.179.7.2363-2372.1997 contributor: fullname: Mio – volume: 52 start-page: 1127 issue: 3 year: 2008 ident: 10.1016/j.jsps.2013.12.007_b0310 article-title: Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01397-07 contributor: fullname: Uppuluri – volume: 49 start-page: 973 issue: 6 year: 2002 ident: 10.1016/j.jsps.2013.12.007_b0250 article-title: Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkf049 contributor: fullname: Ramage – volume: 41 start-page: 1082 year: 2010 ident: 10.1016/j.jsps.2013.12.007_b0275 article-title: Quantification of biofilm production on polystyrene by Listeria, Escherichia coli and Staphylococcus aureus isolated from a poultry slaughterhouse publication-title: Braz. J. Microbiol. doi: 10.1590/S1517-83822010000400029 contributor: fullname: Rodrigues – volume: 310 start-page: 566 year: 1999 ident: 10.1016/j.jsps.2013.12.007_b0305 article-title: Detection of prosthetic joint biofilm infection using immunological and molecular techniques publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(99)10044-2 contributor: fullname: Tunney – volume: 8 start-page: 1392 issue: 12 year: 2012 ident: 10.1016/j.jsps.2013.12.007_b0070 article-title: Exoenzymes production and antifungal susceptibility of candida species isolated from pregnant women with vulvovaginitis publication-title: J. Am. Sci. contributor: fullname: Emam – volume: 310 start-page: 644 year: 1999 ident: 10.1016/j.jsps.2013.12.007_b0025 article-title: Candida biofilms and their susceptibility to antifungal agents publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(99)10050-8 contributor: fullname: Baillie – volume: 11 start-page: 239 year: 2007 ident: 10.1016/j.jsps.2013.12.007_b0005 article-title: Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital 1996–2004 publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2006.03.003 contributor: fullname: Al-Tawfiq |
SSID | ssj0025593 |
Score | 2.1089416 |
Snippet | Biofilm formation is often associated with increased Candida resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of... Biofilm formation is often associated with increased Candida resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 55 |
SubjectTerms | Antifungal Biofilm Candida spp CDR1 KRE1 Original SKN1 |
SummonAdditionalLinks | – databaseName: ScienceDirect dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhl_ZS2vS1bRJUKLk0Zi1Lsq1jujSEQkugCexNWK_UgXiXePeQn9F_nBnJ3mTb0kPBLHg9WoRm9M0n7zwI-ehMaVVQTZbbmmeigQ8DNCFrSlkJqQRQeswd_va9PLsUX-dyvkNmYy4MhlUO2J8wPaL18M10WM3psm2nPxhHZ1YiCsem2YDDXLKYxDf_vDl0yVR4l8VkHZAeEmdSjNd1v8SS3YzHV4LYUvbvzulP8vl7DOUjp3T6nDwb2CQ9SRN-QXZ8t0eezMYmbnvk6DyVpr47phcPmVb9MT2i5w9Fq-9ekl_wmKbgDroItMEYIsAB-HFYGTg9RwVSuFbo3CLU9FGQ9gA9Pg5yt-urDI7vSElhHekV4ihtOzqmX9IWLB3JLUrPMKHGwfilh3VHOQdm5qhpsYv4Tf-KXJ5-uZidZUO7hszKQq6yANu_Vs4DYQgA594GZVRZF9Za4wzwhJKLOheWCdj3wjmlBDOO5aZgDg6NNX9NdrtF598Sar10wRrOLDci1LzJK88bDBjIbTBlmJBPo570MlXl0GO42rVGrWrUqmaFBq1OiBxVqbdsS4Pb-Oe4D6PeNagN_0lpOr9Y95qVUlaFqBSbkDfJDjbzAA5Zy1yICam2LGQjgAW9t5907c9Y2FtgmdZSvPvP-b4nT-FOphdE-2R3dbv2B0CZVuYw7ol7q70ZMg priority: 102 providerName: Elsevier |
Title | The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms |
URI | https://dx.doi.org/10.1016/j.jsps.2013.12.007 https://www.ncbi.nlm.nih.gov/pubmed/25685044 https://search.proquest.com/docview/1655724791 https://pubmed.ncbi.nlm.nih.gov/PMC4310964 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61vcAFQXltgcpIqBeabpzYSXyEFVUBFS1SK-3Nih9pU3Wzq2b30J_BP2Zsxy1tBQekyJeMI0vzeeYbZ2YM8MGoQotG1EmqqzxhNQ4KaUJSF7xkXDCk9K52-PhHcXTKvs34bAN4rIXxSftatQfd5fyga899buVyrscxT2w8PZ4w186yYONN2ESAxhB9iLJ46LRLfXUOBgNDpUxI6rrol65HN839GWDqruBDn1_xlLG_OaaHxPN-_uQfDunwKTwZmCT5FFb8DDZstw2PJvECt23Ym4a21Nf75OS2yqrfJ3tketuw-vo5_MLXJCR2kEVDapc_hDYAP45wxMjZK4_gs3KOzZuZ3guSHs2O9ZPM1foswdDd0VHEETlzNpS0HYmll6RFlDti66QnrpjG4PylRdvi5AxCzBDVuhvE5_0LOD38cjI5SoarGhLNM75KGtz6lTAWyUKDptzqRihRVJnWWhmFHKHIWZUyTRnueWaMEIwqQ1OVUYMBY5W_hK1u0dnXQLTlptEqpzpXrKnyOi1tXrtkgVQ3qmhG8DHqSS5DRw4ZU9UupFOwdAqWNJOo4BHwqEo5cIrAFSS6jH_Oex_1LlFt7i9K3dnFupe04LzMWCnoCF4FHNysI2JpBOUdhNwIuGbed98gxn1T7wHTO_898w08xvXzcDz0FrZWV2v7DgnTSu36gwYcv84-4_j9Z7Xrt8xveCYcIw |
link.rule.ids | 230,315,730,783,787,867,888,3513,27936,27937,45886,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VcigXBOUVnouEeqFWvN5dP44QUaXQVpVIpdxW3oeLK-FEdXLoz-AfM7O2UwKIA1KUQ3Y2Wu3MfvOtPQ-Ad86ktqiKMoptLiJZ4pdBmhCVqcqkKiRSesodPj1Lpxfy81zNd2Ay5MJQWGWP_R2mB7Tufxn3uzle1vX4KxfkzFJC4dA0-w7cpbRLMvPj-cfNrUt1lXd5yNZB8T5zpgvyumqXVLObi_BMkHrK_t07_ck-fw-i_MUrHT2A-z2dZB-6FT-EHd_sw95k6OK2DwfnXW3qm0M2u021ag_ZATu_rVp98wh-4DDrojvYomIlBREhEOCf49bg9TlokOFnRd4tYE0bBFmL2OPDJHe9vozw_k6cFDeSXRKQsrphQ_4lq9HUid2S9IQyahzOX3rceJJzaGeOmZraiH9vH8PF0afZZBr1_RoiqxK1iio8_3nhPDKGCvHc26owRZon1lrjDBKFVMg8lpZLPPjSuaKQ3Dgem4Q7vDXm4gnsNovGPwNmvXKVNYJbYWSVizLOvCgpYiC2lUmrEbwf9KSXXVkOPcSrXWnSqiatap5o1OoI1KBKvWVcGv3GP-e9HfSuUW30KqVs_GLdap4qlSUyK_gInnZ2sFkHkshcxVKOINuykI0AVfTeHmnqb6Gyt6Q6ral8_p_rfQN709npiT45PvvyAu7hiOqeFr2E3dX12r9C_rQyr8P5-An1ABxg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSMClKgXKFgpGQr3QdOPEduJjtWVVHq320Eq9WfGrpGKzUbN76M_gHzO2kz5AcEBa7SX2Kqv5PPNN8s0MQh-M4lo4USWpLvOEVvClgCYkFWcFZYICpfe1w8cn_OiMfjln53dGfQXRvlb1fvNjvt_U34O2sp3r8aATG8-OJ9S3s-R03Bo3fogewZlN-ZCo97kWi_12SajRgZSgr5eJ0q7LrvWdukkengSmfhAfRP6SpZT-LTz9ST9_V1HeCUvTDbTe80l8EO_7GXpgm030ZDKMcdtEu7PYnPp6D5_e1lp1e3gXz27bVl8_Rz_hMo7yDrxwuPIqIvAE8OMASsifgwkxfJY-vAVn04WFuAPnY8Mmc7W6SCCB96QU0IQvvCfFdYOHAkxcA9Y9vfWrJ76kxsD-1oKH8esMAM1gVfs54vPuBTqbfjqdHCX9wIZEs4wtEwcOoBTGAmVw4NCtdkIJXmZaa2UUMAWe0zKlmlA4-dQYIShRhqQqIwbSxjJ_idaaRWNfIawtM06rnOhcUVfmVVrYvPKSgVQ7xd0IfRzsJNvYl0MOgrVL6Q0svYElySQYeITYYErZM4vIGCQEjn_uez_YXYLZ_LuUqrGLVScJZ6zIaCHICG1FHNzcx4ClESruIeRmgW_pff8KID209u6Rvf3fO9-hx7PDqfz2-eTra_QU_gqLz4veoLXl1cruAINaqrfhrPwCffsdng |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+antifungal+combination+on+transcripts+of+a+subset+of+drug-resistance+genes+in+clinical+isolates+of+Candida+species+induced+biofilms&rft.jtitle=Saudi+pharmaceutical+journal&rft.au=Ibrahim%2C+Nermin+H&rft.au=Melake%2C+Nahla+A&rft.au=Somily%2C+Ali+M&rft.au=Zakaria%2C+Azza+S&rft.date=2015-01-01&rft.issn=1319-0164&rft.volume=23&rft.issue=1&rft.spage=55&rft.epage=66&rft_id=info:doi/10.1016%2Fj.jsps.2013.12.007&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1319-0164&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1319-0164&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1319-0164&client=summon |